Neurocrine Biosciences, Inc. company logo
Neurocrine Biosciences, Inc. logo

Neurocrine Biosciences, Inc. (NBIX) Selling, General & Administrative Expenses

Annual SG&A

$1.01B$119.60M+13.47%

Summary

Current Value
As of today, NBIX annual SG&A is $1.01B, up +13.47% on
Historical Performance
NBIX annual SG&A is up +72.67% over the past 3 years, and up +184.44% over the past 5 years
All-Time High Comparison
NBIX annual SG&A is currently at its all-time high
3-Year Low Comparison
NBIX annual SG&A is +33.81% above its 3-year low of $752.70M reached on an earlier date
Sector Comparison
NBIX annual SG&A is higher than 96.62% of companies in Healthcare sector

SG&A Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

NBIX Performance
MetricDateValue1Y3Y5Y15Y
Annual SG&A$1.01B+13.5%+72.7%+184.4%+4850.9%
Quarterly SG&A$0.00-100.0%-100.0%-100.0%-100.0%
TTM SG&A$402.40M-57.1%-44.6%-6.0%+3046.0%
Price$140.62+2.2%+14.3%+36.8%+1777.4%
Annual Operating Expenses$1.74B+19.7%+90.7%+213.7%+3115.1%
Annual Operating Profit$583.00M+47.7%+180.6%+157.3%+1240.6%
Annual D&A$27.10M+27.2%+148.6%+266.2%+752.5%
Annual Revenue$2.36B+24.8%+107.8%+198.9%+10000.0%

SG&A Highs

NBIX Annual SG&A Highs Comparison
PeriodHighDateCurrent
3Y$1.01Bat high
5Y$1.01Bat high
All$1.01Bat high

SG&A Lows

NBIX Annual SG&A Lows Comparison
PeriodLowDateCurrent
3Y$752.70MN/A+33.8%
5Y$433.30MN/A+132.4%
All$3.70M>+9999.0%

SG&A History

YearValueChange
$1.01B+13.5%
$887.60M+17.9%
$752.70M+29.0%
$583.30M+34.6%
$433.30M+22.4%
$354.10M+42.3%
YearValueChange
$248.90M+46.5%
$169.91M+149.6%
$68.08M+109.6%
$32.48M+80.6%
$17.99M-

FAQ

  • What is the current annual SG&A of NBIX?

    As of today, NBIX annual SG&A is $1.01B

  • What is 1-year change in NBIX annual SG&A?

    NBIX annual SG&A is up +13.47% year-over-year

  • What is 3-year change in NBIX annual SG&A?

    NBIX annual SG&A is up +72.67% over the past 3 years

  • How far is NBIX annual SG&A from its all-time high?

    NBIX annual SG&A is currently at its all-time high

  • How does NBIX annual SG&A rank versus sector peers?

    NBIX annual SG&A is higher than 96.62% of companies in Healthcare sector

  • When is NBIX next annual earnings release?

    The next annual earnings release for NBIX is on

Selling, General & Administrative Expenses Formula

SG&A = − R&D

Data Sources & References

  1. NBIX Official Website www.neurocrine.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/914475/000091447525000181/0000914475-25-000181-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/914475/000091447525000037/0000914475-25-000037-index.htm
  4. NBIX Profile on Yahoo Finance finance.yahoo.com/quote/NBIX
  5. NBIX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nbix